HIV/AIDS, TB, Malaria Portfolio
Infectious Diseases
Key Facts
About Strides Pharma
Strides Pharma Science Limited is a multinational pharmaceutical company with a mission to make quality healthcare accessible globally through a hybrid business model spanning regulated and emerging markets. Founded in 1990, it has evolved from a domestic Indian manufacturer into a global leader in complex generics and specialty pharmaceuticals, leveraging a vertically integrated structure with advanced manufacturing and R&D. Key achievements include a 5x increase in Q4 FY2025 net profit, a strategic 'In Africa, For Africa' initiative, and a robust portfolio of USFDA-approved facilities, positioning it for sustainable growth in the global generics market.
View full company profileOther Infectious Diseases Drugs
| Drug | Company | Phase |
|---|---|---|
| inPROBE Platform | SDS Optic | Early R&D |
| Potential Human POC Diagnostics | MatMaCorp | Research |
| Platform Vaccine Applications | Chimeron Bio | Discovery |
| FMN riboswitch modulator | Acellera | Pre-clinical |
| NP-G2-044 | Novita Pharmaceuticals | Pre-Clinical |
| Ramoplanin™ | Nanopharmaceutics | Clinical |
| NanoDOX™ | Nanopharmaceutics | Clinical |
| Antimicrobial Resistance (AMR) Solutions | Beckman Coulter Diagnostics | Development/Commercialization |
| Infectious Diseases | Menarini | Clinical |
| Undisclosed Infectious Disease Program(s) | ATB therapeutics | Pre-clinical |
| Vaccines for Infectious Diseases (undisclosed) | Takis | Pre-clinical |
| Infectious Disease Diagnostics Program | Aptus Biosciences | Discovery |